Literature DB >> 11346201

Contractile responses to natural tachykinins and selective tachykinin analogs in normal and inflamed ileal and colonic muscle.

A Al-Saffar1, P M Hellström.   

Abstract

BACKGROUND: Tachykinins and acetylcholine are main physiological motility stimulators in the gut by their effects exerted through neurokinin and muscarinic receptors.
METHODS: Longitudinal and circular muscle strips from normal ileum and colon or corresponding tissues from patients with inflammatory bowel disease were studied in organ baths. Contractile responses to the tachykinins substance P, neurokinin A, neurokinin B and neuropeptide gamma and specific analogs for their respective receptors were compared to acetylcholine.
RESULTS: Acetylcholine caused concentration-dependent phasic contractions in longitudinal and circular muscle of normal ileum and colon (both P < 0.01). In inflamed tissues, contractile responses were reduced to 17%-33% in ileum (P < 0.05) and 3%-26% in colon (P < 0.01). Both natural tachykinins and their specific analogs caused concentration-dependent phasic, tonic and rhythmic contractions (each P < 0.01). Neuropeptide gamma was most potent in contracting the ileum and colon, followed by neurokinin A, substance P and neurokinin B, let alone longitudinal muscle of the ileum where neuropeptide gamma and neurokinin A were equipotent. Of the tachykinin analogs, Nle10-NKA(4-10) was more potent than substance P methyl ester and senktide, indicating neurokinin 2 receptors are predominant for contractile effects of tachykinins. In inflamed tissues, contractile responses to tachykinins were reduced to 0%-42% in ileum (P < 0.05) and 0%-17% in colon (P < 0.01) compared to controls.
CONCLUSION: In humans, tachykinins exert gut contractile effects, of similar strength as acetylcholine, predominantly through activation of neurokinin 2 receptors. These responses are greatly reduced in inflamed tissues of ulcerative colitis and Crohn disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346201

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

Review 1.  Gastrointestinal motility disorders in inflammatory bowel diseases.

Authors:  Gabrio Bassotti; Elisabetta Antonelli; Vincenzo Villanacci; Marianna Salemme; Manuela Coppola; Vito Annese
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

2.  Contractile effect of tachykinins on rabbit small intestine.

Authors:  Marta Sofía Valero; Diego Santos Fagundes; Laura Grasa; María Pilar Arruebo; Miguel Ángel Plaza; María Divina Murillo
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

Review 3.  Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contraction.

Authors:  Hiroshi Ozaki; Masatoshi Hori; Kazuya Kinoshita; Takashi Ohama
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 4.  Colonic motility in ulcerative colitis.

Authors:  Gabrio Bassotti; Elisabetta Antonelli; Vincenzo Villanacci; Monia Baldoni; Maria Pina Dore
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

5.  Roles of Toll-Like Receptor 4, IκB Kinase, and the Proteasome in the Intestinal Alterations Caused by Sepsis.

Authors:  Sergio Gonzalo; Marta Sofía Valero; Fernando Martínez de Salinas; Claudia Vergara; María Pilar Arruebo; Miguel Ángel Plaza; María Divina Murillo; Laura Grasa
Journal:  Dig Dis Sci       Date:  2014-11-05       Impact factor: 3.199

6.  Effect of areca on contraction of colonic muscle strips in rats.

Authors:  Dong-Ping Xie; Wei Li; Song-Yi Qu; Tian-Zhen Zheng; Ying-Li Yang; Yong-Hui Ding; Yu-Ling Wei; Lian-Bi Chen
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 7.  Abnormal gut motility in inflammatory bowel disease: an update.

Authors:  G Bassotti; E Antonelli; V Villanacci; R Nascimbeni; M P Dore; G M Pes; G Maconi
Journal:  Tech Coloproctol       Date:  2020-02-15       Impact factor: 3.781

8.  Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; Cariluz Santiago
Journal:  Dig Dis Sci       Date:  2007-05-18       Impact factor: 3.199

9.  Impairment of PAR-2-mediated relaxation system in colonic smooth muscle after intestinal inflammation.

Authors:  Koichi Sato; Hiromichi Ninomiya; Shinsuke Ohkura; Hiroshi Ozaki; Tetsuyuki Nasu
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 10.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.